Tirzepatide Storage: How Long Out of the Fridge?
Researched & written by Alan PierceClinical Pharmacology WriterUpdated
On this page
Tirzepatide — sold as Zepbound and Mounjaro — is normally a refrigerated medicine, so the practical questions come up fast: Did I ruin it by leaving it on the counter? How long can it travel without a cold pack? What if it froze? The good news is that the FDA prescribing information answers these precisely, and the storage limit depends on the exact brand and presentation in your box. This guide quotes those rules so you can act on the actual label, not a forum guess.
A note up front: these are the manufacturer's labeled storage instructions, summarized for general information. Always follow the Instructions for Use that came with your specific pen or vial, and call your pharmacist if you are unsure whether a dose is still safe to use.
The single-dose pen and vial: refrigerate at 36–46°F
The default for the single-dose pen and single-dose vial is the refrigerator. The label says to "Store ZEPBOUND single-dose pen and single-dose vial in a refrigerator at 2°C to 8°C (36°F to 46°F)"1. The Mounjaro label carries word-for-word the same instruction2 for its single-dose presentation. Compare the approved uses in Mounjaro vs Zepbound.
So the baseline is simple: keep it in the fridge, in its original carton to protect it from light, until you need it.
Out of the fridge: up to 21 days at or below 86°F
This is the question most people are really asking. Per the label, "each single-dose pen or single-dose vial can be stored unrefrigerated at temperatures not to exceed 30°C (86°F) for up to a total of 21 days"1. After that, "Discard single-dose pen and single-dose vial after a total of 21 days at room temperature"1.
Two words in that sentence matter. "Total" means the 21 days is cumulative — the unrefrigerated time adds up across the life of that pen or vial; you cannot reset the clock by putting it back in the fridge for a while. And "not to exceed 86°F (30°C)" is a hard ceiling: a hot car, a sunny windowsill, or a beach bag can blow past 86°F quickly, and heat above that limit is not covered by the 21-day allowance. The label is explicit to "Protect ZEPBOUND from heat and light"1.
§ Table 1 — Single-Dose Storage Limits
| Condition | Single-dose pen / vial rule |
|---|---|
| Refrigerated (36–46°F / 2–8°C) | Default storage; keep until expiration, in original carton, protected from light. |
| Room temp (≤86°F / ≤30°C) | Allowed up to a TOTAL of 21 cumulative days; discard after that. |
| Above 86°F / 30°C | Not covered — protect from heat; do not exceed the 86°F ceiling. |
| Frozen | Do not use. Discard. No refreeze, no thaw-and-use exception. |
| Visual check | Must be clear, colorless to slightly yellow, no particles — else discard. |
Never refreeze — and discard if it has frozen
Freezing is the bright line. The label states plainly: "Do not freeze ZEPBOUND. Do not use ZEPBOUND if frozen"1. The Mounjaro label is identical2. There is no thaw-and-use exception. If your pen or vial has frozen — a fridge set too cold, a checked bag in a cold cargo hold, a cold pack pressed directly against it — it should be discarded, not thawed and injected.
This is why a refrigerator that runs too cold can be as much of a problem as one that is too warm. Keep tirzepatide in the main body of the fridge, not against the back wall or in a spot where it can freeze.
Inspect before every injection: clear, colorless, no particles
Even within the temperature rules, the label adds a visual check before you inject. You should make sure the medicine "is not frozen, is not cloudy, is colorless to slightly yellow, [and] does not have particles"1. If it is cloudy, discolored, or has particles in it, do not use it — that is a sign the medicine may have been compromised, regardless of how it was stored.
In short: if it has frozen, looks cloudy, or has anything floating in it, throw it away and use a different dose.
§ Note — Storage Quick Rules
Tirzepatide out of the fridge, by the label
- Default: refrigerate at 36–46°F (2–8°C) in the original carton, away from light.
- Out of the fridge: up to a TOTAL of 21 cumulative days, only if it stays at or below 86°F (30°C).
- The 21-day clock is cumulative — re-refrigerating does not reset it.
- Never refreeze; discard any dose that has frozen (no thaw-and-use exception).
- Inspect every time: clear, colorless to slightly yellow, no particles — otherwise discard.
- Identical rules for Zepbound and Mounjaro; when unsure, ask your pharmacist.
A note on multi-dose vials and KwikPens
The single-dose figures above cover the most common Zepbound and Mounjaro presentations. The multi-dose vial and single-patient-use KwikPen have their own rules: unopened, they can be kept until the expiration date if refrigerated, but if stored at room temperature (up to 86°F) they should be thrown away after 30 days; once opened, the Zepbound label permits refrigerated or room-temperature storage and requires disposal at the earliest of 30 total days at room temperature, 30 days after first use, or four weekly doses1. Always check the Instructions for Use for your specific product, because the in-use limits differ by presentation.
The honest bottom line
For the single-dose pen and vial — the forms most people use — the rules are clear and worth memorizing: keep tirzepatide refrigerated at 36–46°F; if it is out of the fridge, it is good for up to a total of 21 cumulative days as long as it never exceeds 86°F; never refreeze it, and discard any dose that has frozen; and always inspect it to be clear and colorless to slightly yellow with no particles before injecting. Do not apply a single-dose limit to a multi-dose product. When in doubt about a dose that got too warm, too cold, or looks off, the safest move is to call your pharmacist rather than gamble on a compromised injection. For how to give the shot once it is at the right temperature, see how to inject Zepbound; for the full dose schedule, our tirzepatide dosage chart; for the broader evidence picture, the tirzepatide evidence guide; and to weigh providers and pharmacy access, our best tirzepatide overview.
Expired, cloudy or warm deliveries are separate problems
An expiration or beyond-use date, an in-use discard deadline and a temperature allowance answer different questions. A date that has not passed does not prove that the medication was stored correctly. Do not use approved Zepbound that has frozen, contains particles or has discoloration.3
For compounded GLP-1 vials containing multiple doses, FDA currently recommends discarding the vial within 28 days after first use even if the compounder gives a longer period. This recommendation is specific to that compounded-vial context; it is not a replacement for approved-brand presentation instructions.4
FDA also advises against using injectable GLP-1 medicine that arrives warm or inadequately refrigerated. Our warm-delivery guide explains what to document and ask the pharmacy. Cooling it again cannot establish a missing temperature history.
Flying with Zepbound or Mounjaro: airport screening
At a US TSA checkpoint, tell the officer before screening that you are carrying liquid medication and any cooling packs or injection supplies. Place these items separately for inspection. Medically necessary liquids can exceed the usual 3.4-ounce limit in reasonable quantities for your flight, but additional screening may be needed; an unresolved alarm can prevent an item from passing. 5
Unused syringes may travel with the injectable medication they are for. Declare them for inspection. TSA recommends medication labeling to make screening easier, although its syringe guidance does not require a label. 6
Cooling packs used for medically necessary items may be frozen, partly frozen or melted at screening. They and your medication still need inspection. If you do not want liquid medicine X-rayed or opened, tell the officer before screening; additional screening procedures may follow. 5
Airport permission does not change the medicine’s storage limits. Use the exact presentation rules above, keep Zepbound protected from heat and light in its original carton, and do not freeze it or use it after freezing. 3 For a delivery-temperature problem, see tirzepatide that arrived warm.
These TSA procedures apply to US screening. Check your airline and destination’s medication-entry requirements before international travel; this section does not establish foreign customs permission.
Frequently asked questions
How long can tirzepatide stay out of the fridge?
Per the FDA label, a single-dose pen or vial can be stored unrefrigerated for up to a total of 21 days, as long as the temperature never exceeds 86°F (30°C). The 21 days is cumulative across the life of that pen or vial, so it cannot be reset by putting it back in the fridge. After 21 days at room temperature it must be discarded.
Can I refreeze tirzepatide if it got cold?
No. The label says do not freeze tirzepatide and do not use it if it has frozen. There is no thaw-and-use exception — a pen or vial that has frozen should be discarded, not thawed and injected.
What temperature should tirzepatide be stored at?
In the refrigerator at 36–46°F (2–8°C), kept in its original carton to protect it from light. If out of the fridge, it must stay at or below 86°F (30°C) and only for the allowed unrefrigerated window.
How do I know if my tirzepatide has gone bad?
Inspect it before every injection. The medicine should be clear and colorless to slightly yellow with no particles. If it is cloudy, discolored, has particles, or has been frozen, do not use it — discard it and use a different dose, and ask your pharmacist if you are unsure.
References(6)
- Eli Lilly and Company (manufacturer label) (2025). ZEPBOUND (tirzepatide) injection — FDA prescribing information (Section 16.2 Storage and Handling; Instructions for Use). DailyMed (NIH/NLM), FDA label. Read source
- Eli Lilly and Company (manufacturer label) (2025). MOUNJARO (tirzepatide) injection — FDA prescribing information (Section 16.2 Storage and Handling). DailyMed (NIH/NLM), FDA label. Read source
- Eli Lilly and Company (2026). Zepbound prescribing information (revised August 2026). FDA-approved prescribing information. Read source
- FDA (2026). FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA. Read source
- Transportation Security Administration (2026). Disabilities and Medical Conditions: Medications. TSA. Read source
- Transportation Security Administration (2017). Unused Syringes. TSA. Read source
About the author
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Continue reading
Browse the research libraryMounjaro vs Zepbound: Same Drug, Different Approvals
Mounjaro and Zepbound are the identical tirzepatide molecule. What differs is the FDA indication, insurance coverage, and packaging — not the potency.
ReadHow & Where to Inject Zepbound: Step-by-Step (Pen & Vial)
A label-sourced walkthrough of injecting Zepbound (tirzepatide) — the pen, the vial, where to inject, site rotation, timing, storage, and sharps disposal.
ReadTirzepatide Dosage Chart: Full Titration Schedule
Every tirzepatide dose from 2.5 to 15 mg, the four-week steps, the missed-dose rule and dosing in units — read off the FDA Zepbound and Mounjaro labels.
ReadTirzepatide: Evidence, Dosing & Side Effects
An evidence-based guide to tirzepatide: how the dual GIP/GLP-1 drug works, what the trials show, the dosing ladder, side effects, and the ongoing-use reality.
ReadTirzepatide Arrived Warm? What to Do Before Injecting
What to do when tirzepatide delivery arrives warm, inadequately refrigerated or damaged, and why storage rules cannot prove a shipment was safe.
Read